These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34746853)

  • 41. Generation of mouse hippocampal neural precursor cell lines with CRISPR/Cas9-mediated gene knockouts.
    Zocher S; Kempermann G
    STAR Protoc; 2021 Jun; 2(2):100472. PubMed ID: 33948565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protocol for gene characterization in Aspergillus niger using 5S rRNA-CRISPR-Cas9-mediated Tet-on inducible promoter exchange.
    Zheng X; Cairns T; Zheng P; Meyer V; Sun J
    STAR Protoc; 2022 Dec; 3(4):101838. PubMed ID: 36595926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
    Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
    J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One-step CRISPR-Cas9 protocol for the generation of plug & play conditional knockouts in
    Yu JJS; Vincent JP; McGough IJ
    STAR Protoc; 2021 Jun; 2(2):100560. PubMed ID: 34095868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression.
    Pantina VD; Verona F; Turdo A; Veschi V; Modica C; Lo Iacono M; Gaggianesi M; Di Bella S; Todaro M; Di Franco S; Stassi G
    STAR Protoc; 2024 Sep; 5(3):103263. PubMed ID: 39128010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.
    Ten Hacken E; Gruber M; Hernández-Sánchez M; Hoffmann GB; Baranowski K; Redd RA; Clement K; Livak K; Wu CJ
    STAR Protoc; 2023 Dec; 4(4):102165. PubMed ID: 37729058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
    Li K; Cai D; Wang Z; He Z; Chen S
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficient generation of locus-specific human CAR-T cells with CRISPR/cCas12a.
    Ling X; Chang L; Chen H; Liu T
    STAR Protoc; 2022 Jun; 3(2):101321. PubMed ID: 35496795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protocol for the Generation of Human Pluripotent Reporter Cell Lines Using CRISPR/Cas9.
    Zhong A; Li M; Zhou T
    STAR Protoc; 2020 Sep; 1(2):. PubMed ID: 33073252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploiting CRISPR/Cas9 to engineer precise segmental deletions in mouse embryonic stem cells.
    Elango R; Panday A; Willis NA; Scully R
    STAR Protoc; 2022 Sep; 3(3):101551. PubMed ID: 36042887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient genome editing in wheat using Cas9 and Cpf1 (AsCpf1 and LbCpf1) nucleases.
    Kim D; Hager M; Brant E; Budak H
    Funct Integr Genomics; 2021 Jul; 21(3-4):355-366. PubMed ID: 33710467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast.
    Zhang XR; He JB; Wang YZ; Du LL
    G3 (Bethesda); 2018 May; 8(6):2067-2077. PubMed ID: 29703785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting endogenous proteins for spatial and temporal knockdown using auxin-inducible degron in Caenorhabditis elegans.
    Kurashina M; Mizumoto K
    STAR Protoc; 2023 Mar; 4(1):102028. PubMed ID: 36640369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
    Dong W; Kantor B
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Highly efficient genome editing in N. gerenzanensis using an inducible CRISPR/Cas9-RecA system.
    Yue X; Xia T; Wang S; Dong H; Li Y
    Biotechnol Lett; 2020 Sep; 42(9):1699-1706. PubMed ID: 32314149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.